Renaissance Capital logo

FJDIU News

US IPO Weekly Recap: August kicks off with flurry of biotech IPOs

Six IPOs and five SPACs priced this week. Two IPOs and eight SPACs submitted filings. Cardiovascular disease biotech Braveheart Bio (BRVE) upsized and priced above the range, raising $383 million at a $1.6 billion market cap. Its lead candidate, BHB-1893, is ...read more

SPAC ARC Group Securities Acquisition I prices $105 million IPO, led by ARC Group executives

ARC Group Securities Acquisition I, a blank check company led by ARC Group executives, raised $105 million by offering 10.5 million units at $10. Each unit consists of one share of common stock, one warrant exercisable at $11.50, and one right to receive...read more

SPAC ARC Group Securities Acquisition I decreases units offered by 30% and adds CFO ahead of $105 million IPO

ARC Group Securities Acquisition I, a blank check company led by ARC Group executives, lowered the proposed deal size for its upcoming IPO on Tuesday. The Tempe, AZ-based company now plans to raise $105 million by offering 10.5 million units at $10. The...read more

US IPO Weekly Recap: Beta Technologies leads 6 deal week to open November

Six IPOs debuted this week, raising a combined $1.8 billion. Four SPACs also listed. One IPO and seven SPACs submitted initial filings. Leading the pack, electric aircraft manufacturer Beta Technologies (BETA) priced its upsized IPO above the range to raise...read more